Virtual webinar scheduled for Wednesday, May 13, 2026, 11am–12pm EDT, focusing on using BioGPU runtime to enable AI models to interact with cellular biology in real-time.
Introduces visual computing for high-content imaging of pathway-level biology in cells, generating disease models for AI analysis.
BioGPU agent allows AI (e.g., ChatGPT, Gemini) to 'chat with cells' through loops of hypothesis, experiments, and refinement to resolve target functions, regulation, and compound mechanisms including off-target effects.
Features case studies in rheumatoid arthritis and ALS, demonstrating deprioritization of inactive pathways and identification of novel targets.
Presented by Anima Biotech, advancing AI-native discovery via iterative AI-BioGPU loops.